Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Global chemical effects of the microbiome include new bile-acid conjugations.

Quinn RA, Melnik AV, Vrbanac A, Fu T, Patras KA, Christy MP, Bodai Z, Belda-Ferre P, Tripathi A, Chung LK, Downes M, Welch RD, Quinn M, Humphrey G, Panitchpakdi M, Weldon KC, Aksenov A, da Silva R, Avila-Pacheco J, Clish C, Bae S, Mallick H, Franzosa EA, Lloyd-Price J, Bussell R, Thron T, Nelson AT, Wang M, Leszczynski E, Vargas F, Gauglitz JM, Meehan MJ, Gentry E, Arthur TD, Komor AC, Poulsen O, Boland BS, Chang JT, Sandborn WJ, Lim M, Garg N, Lumeng JC, Xavier RJ, Kazmierczak BI, Jain R, Egan M, Rhee KE, Ferguson D, Raffatellu M, Vlamakis H, Haddad GG, Siegel D, Huttenhower C, Mazmanian SK, Evans RM, Nizet V, Knight R, Dorrestein PC.

Nature. 2020 Mar;579(7797):123-129. doi: 10.1038/s41586-020-2047-9. Epub 2020 Feb 26.

PMID:
32103176
2.

The Fungal Pathogen Candida albicans Promotes Bladder Colonization of Group B Streptococcus.

Shing SR, Ramos AR, Patras KA, Riestra AM, McCabe S, Nizet V, Coady A.

Front Cell Infect Microbiol. 2020 Jan 10;9:437. doi: 10.3389/fcimb.2019.00437. eCollection 2019.

3.

Determinants of Group B streptococcal virulence potential amongst vaginal clinical isolates from pregnant women.

Burcham LR, Spencer BL, Keeler LR, Runft DL, Patras KA, Neely MN, Doran KS.

PLoS One. 2019 Dec 18;14(12):e0226699. doi: 10.1371/journal.pone.0226699. eCollection 2019.

4.

Cas9 Contributes to Group B Streptococcal Colonization and Disease.

Spencer BL, Deng L, Patras KA, Burcham ZM, Sanches GF, Nagao PE, Doran KS.

Front Microbiol. 2019 Aug 21;10:1930. doi: 10.3389/fmicb.2019.01930. eCollection 2019.

5.

Augmentation of Urinary Lactoferrin Enhances Host Innate Immune Clearance of Uropathogenic Escherichia coli.

Patras KA, Ha AD, Rooholfada E, Olson J, Ramachandra Rao SP, Lin AE, Nizet V.

J Innate Immun. 2019;11(6):481-495. doi: 10.1159/000499342. Epub 2019 May 3.

6.

Inhibition of Human Neutrophil Extracellular Trap (NET) Production by Propofol and Lipid Emulsion.

Meier A, Chien J, Hobohm L, Patras KA, Nizet V, Corriden R.

Front Pharmacol. 2019 Apr 5;10:323. doi: 10.3389/fphar.2019.00323. eCollection 2019.

7.

The murine vaginal microbiota and its perturbation by the human pathogen group B Streptococcus.

Vrbanac A, Riestra AM, Coady A, Knight R, Nizet V, Patras KA.

BMC Microbiol. 2018 Nov 26;18(1):197. doi: 10.1186/s12866-018-1341-2.

8.

Trichomonas vaginalis Induces NLRP3 Inflammasome Activation and Pyroptotic Cell Death in Human Macrophages.

Riestra AM, Valderrama JA, Patras KA, Booth SD, Quek XY, Tsai CM, Nizet V.

J Innate Immun. 2019;11(1):86-98. doi: 10.1159/000493585. Epub 2018 Nov 2.

9.

Tamm-Horsfall Protein Protects the Urinary Tract against Candida albicans.

Coady A, Ramos AR, Olson J, Nizet V, Patras KA.

Infect Immun. 2018 Nov 20;86(12). pii: e00451-18. doi: 10.1128/IAI.00451-18. Print 2018 Dec.

10.

Group B Streptococcus Biofilm Regulatory Protein A Contributes to Bacterial Physiology and Innate Immune Resistance.

Patras KA, Derieux J, Al-Bassam MM, Adiletta N, Vrbanac A, Lapek JD, Zengler K, Gonzalez DJ, Nizet V.

J Infect Dis. 2018 Oct 5;218(10):1641-1652. doi: 10.1093/infdis/jiy341.

11.

Group B Streptococcal Maternal Colonization and Neonatal Disease: Molecular Mechanisms and Preventative Approaches.

Patras KA, Nizet V.

Front Pediatr. 2018 Feb 22;6:27. doi: 10.3389/fped.2018.00027. eCollection 2018. Review.

12.

Tamm-Horsfall glycoprotein engages human Siglec-9 to modulate neutrophil activation in the urinary tract.

Patras KA, Coady A, Olson J, Ali SR, RamachandraRao SP, Kumar S, Varki A, Nizet V.

Immunol Cell Biol. 2017 Nov;95(10):960-965. doi: 10.1038/icb.2017.63. Epub 2017 Aug 22.

13.

A Murine Model of Group B Streptococcus Vaginal Colonization.

Patras KA, Doran KS.

J Vis Exp. 2016 Nov 16;(117). doi: 10.3791/54708.

14.

Identification of CiaR Regulated Genes That Promote Group B Streptococcal Virulence and Interaction with Brain Endothelial Cells.

Mu R, Cutting AS, Del Rosario Y, Villarino N, Stewart L, Weston TA, Patras KA, Doran KS.

PLoS One. 2016 Apr 21;11(4):e0153891. doi: 10.1371/journal.pone.0153891. eCollection 2016.

15.

Streptococcus salivarius K12 Limits Group B Streptococcus Vaginal Colonization.

Patras KA, Wescombe PA, Rösler B, Hale JD, Tagg JR, Doran KS.

Infect Immun. 2015 Sep;83(9):3438-44. doi: 10.1128/IAI.00409-15. Epub 2015 Jun 15.

16.

Characterization of host immunity during persistent vaginal colonization by Group B Streptococcus.

Patras KA, Rösler B, Thoman ML, Doran KS.

Mucosal Immunol. 2015 Nov;8(6):1339-48. doi: 10.1038/mi.2015.23. Epub 2015 Apr 8.

17.

Analysis of two-component systems in group B Streptococcus shows that RgfAC and the novel FspSR modulate virulence and bacterial fitness.

Faralla C, Metruccio MM, De Chiara M, Mu R, Patras KA, Muzzi A, Grandi G, Margarit I, Doran KS, Janulczyk R.

mBio. 2014 May 20;5(3):e00870-14. doi: 10.1128/mBio.00870-14.

18.

Group B streptococcal serine-rich repeat proteins promote interaction with fibrinogen and vaginal colonization.

Wang NY, Patras KA, Seo HS, Cavaco CK, Rösler B, Neely MN, Sullam PM, Doran KS.

J Infect Dis. 2014 Sep 15;210(6):982-91. doi: 10.1093/infdis/jiu151. Epub 2014 Mar 11.

19.

A novel C5a-derived immunobiotic peptide reduces Streptococcus agalactiae colonization through targeted bacterial killing.

Cavaco CK, Patras KA, Zlamal JE, Thoman ML, Morgan EL, Sanderson SD, Doran KS.

Antimicrob Agents Chemother. 2013 Nov;57(11):5492-9. doi: 10.1128/AAC.01590-13. Epub 2013 Aug 26.

20.

Group B Streptococcus CovR regulation modulates host immune signalling pathways to promote vaginal colonization.

Patras KA, Wang NY, Fletcher EM, Cavaco CK, Jimenez A, Garg M, Fierer J, Sheen TR, Rajagopal L, Doran KS.

Cell Microbiol. 2013 Jul;15(7):1154-67. doi: 10.1111/cmi.12105. Epub 2013 Jan 30.

Supplemental Content

Loading ...
Support Center